Humana (NYSE:HUM) Reaches New 1-Year Low – What’s Next?

Humana Inc. (NYSE:HUM) shares reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $168.61 and last traded at $167.9490, with a volume of 163210 shares trading hands. The stock had previously closed at $170.95.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on HUM. Weiss Ratings restated a “sell (d+)” rating on shares of Humana in a research report on Thursday, January 22nd. KeyCorp reissued a “sector weight” rating on shares of Humana in a report on Friday, December 12th. Evercore decreased their price target on shares of Humana from $260.00 to $180.00 in a research report on Thursday, February 12th. Barclays cut their price objective on shares of Humana from $245.00 to $176.00 and set an “equal weight” rating for the company in a research report on Tuesday, February 24th. Finally, Morgan Stanley set a $146.00 target price on Humana in a research report on Thursday, February 12th. Seven investment analysts have rated the stock with a Buy rating, sixteen have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, Humana presently has an average rating of “Hold” and a consensus price target of $225.48.

Humana Price Performance

The company has a current ratio of 2.00, a quick ratio of 2.00 and a debt-to-equity ratio of 0.70. The company has a market cap of $20.11 billion, a P/E ratio of 17.10, a P/E/G ratio of 1.78 and a beta of 0.44. The firm has a 50 day moving average of $216.73 and a 200-day moving average of $249.74.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($4.01) by $0.05. Humana had a net margin of 0.92% and a return on equity of 11.43%. The company had revenue of $32.64 billion for the quarter, compared to the consensus estimate of $32.08 billion. During the same quarter in the prior year, the firm earned ($2.16) earnings per share. Humana’s revenue was up 11.3% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. On average, equities research analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be given a $0.885 dividend. The ex-dividend date is Friday, March 27th. This represents a $3.54 annualized dividend and a yield of 2.1%. Humana’s dividend payout ratio (DPR) is currently 36.05%.

Insiders Place Their Bets

In related news, insider Sanjay K. Shetty acquired 810 shares of Humana stock in a transaction on Monday, February 23rd. The shares were bought at an average cost of $185.21 per share, with a total value of $150,020.10. Following the completion of the purchase, the insider directly owned 11,657 shares of the company’s stock, valued at $2,158,992.97. The trade was a 7.47% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.37% of the stock is owned by insiders.

Hedge Funds Weigh In On Humana

A number of institutional investors and hedge funds have recently modified their holdings of HUM. Montag A & Associates Inc. lifted its position in Humana by 1,880.0% in the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after buying an additional 94 shares during the last quarter. CoreCap Advisors LLC grew its position in Humana by 54.4% in the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 37 shares during the last quarter. Fideuram Asset Management Ireland dac bought a new stake in shares of Humana during the fourth quarter worth $27,000. Reflection Asset Management purchased a new stake in shares of Humana during the fourth quarter valued at $29,000. Finally, Rosenberg Matthew Hamilton grew its holdings in shares of Humana by 136.0% in the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after purchasing an additional 68 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.